Impaired Risk Review: Insurance with HIV
From the initial recognition of HIV virus in 1981, HIV infection has turned from an almost universally fatal infection, to one that could be managed with medication to extend life, to a disease which can be controlled with newer and revolutionary medication therapies. While many companies continue to see the HIV virus as uninsurable, that corner has also been turned, and life insurance in selected cases of treated HIV infection is now possible. Even though the conditions that must be met are numerous and the criteria stringent, applicants with HIV now have the possibility of acceptable insurance offers.
Impaired Risk View: Hemophilia
Once a disastrous disease with markedly shortened life expectancy, hemophilia is now both a treatable as well as insurable disease in most instances. It is important to realize that hemophilia not only comes in many types, but also in many degrees of severity.
Impaired Risk Review: Hypertriglyceridemia
Most of us are programmed to know what our cholesterol levels are, and doctors are constantly cautioning us to watch our cholesterol or to take medication which helps in lowering our blood level. High cholesterol in addition to such health conditions as heart disease, diabetes, hypertension and vascular disease pose higher risks in overall health and in underwriting. How about triglyceride levels however? They are part of virtually every comprehensive medical panel and enter into underwriting and health risk as well.
Impaired Risk Review: White Coat Hypertension
Blood pressure readings are part of virtually every physician encounter and of course every paramedical exam for insurance. Hypertension, or high blood pressure, has been well studied as a risk factor in health and disease. The term white coat hypertension, or white coat syndrome, is used to describe individuals whose blood pressure in a clinical setting is significantly higher (or out of normal range) than in normal daytime situations, and believed to be due to transient anxiety during a doctor or medical visit.
Impaired Risk Review: Crediting Systems
Once upon a time, being a standard risk in the underwriting process was the best you could hope for. It meant that your health was at the top of the group of insured lives being considered and eligible for the best rate, and that you would live all the way out to the prediction of the actuarial life tables. Now, life insurers have created a whole tier of preferred and super preferred pricing that makes a standard issue almost seem like a rated policy.
The Revolution in Impaired Risk Underwriting
Insurers have developed mathematical algorithms to determine where they can speed up the underwriting process
Impaired Risk Review: Gestational Diabetes
Gestational diabetes is a term used to describe diabetes or abnormal glucose tolerance discovered during pregnancy. While many women enter pregnancy with a diagnosis of diabetes (whether on medication or not), gestational diabetes is used to describe diabetes that is diagnosed in the second half of pregnancy.
Impaired Risk Review: Ventricular Premature Beats
Not everyone who has PVCs needs to see a cardiologist, or has a serious health problem, but some do and those are the ones underwriters look at most carefully.
Impaired Risk Review: Informal Applications
Sometimes agents, brokers and even applicants would like to have a general idea of how their insurance application will proceed before an official submission is made. There are all sorts of reasons for this, which may include whether their medical condition is insurable, whether their finances or accompanying information qualify them for the coverage they are requesting, and, if the application is going to be rated, to what degree and what kind of resulting premium they can expect. An informal application allows the underwriter (and often the doctor) to review information that would be submitted as part of the application and give a good idea of the risk assessment to follow.
Impaired Risk Review: Pancreatic Cancer: Still a Killer
Much progress has been made in combating cancer, but pancreatic cancer still sticks its ruthless head up as an actually increasing and an equally deadly one. In 2016, The American Cancer Society estimates almost 55,000 new diagnoses of pancreatic cancer will be made and 42,000 deaths will ensue.